New patent for Astellas drug XOSPATA
Annual Drug Patent Expirations for XOSPATA Xospata is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source
Annual Drug Patent Expirations for XOSPATA Xospata is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from three suppliers. There are sixteen…
Source
This chart shows the drugs with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical drugs have the most drug patents in South Africa? Read Post »
Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are thirteen…
Source
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier. There are sixteen patents protecting…
Source
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are three patents…
Source
New patent expiration for Aveo Pharms drug FOTIVDA Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Topiramate is the generic in…
New tentative approval for Xiamen Lp drug topiramate Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Luxembourg. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Luxembourg? Read Post »
Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four…
Source
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
Source
Get new actionable insights and updates from BiotechBlog